Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer: Los Angeles Thursday, July 17, 2025, 15:00 Hrs [IST] Kairos Pharma, Ltd., a clini ...

US President Donald Trump has been diagnosed with chronic venous insufficiency, following swelling in his lower legs.

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

When you’re looking for solutions to improve your intimate function, it’s easy to get overwhelmed by the vast array of ...

Two and a half years ago, the Cubs signaled that the rebuild was over and they were getting serious about winning by signing ...

Company touted Kisqali's "replacement power" as another blockbuster faces generic competition and expressed optimism about ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Swiss pharmaceuticals giant Novartis posted Thursday a 29 percent increase in first-half net income, at $7.6 billion -- and ...